Hypertension is often a dose-limiting toxicity for VEGFR inhibition, which may be a mechanism-dependent, “on-target” toxicity of the VEGF signaling pathway rather than non-specific effects on unrelated signaling pathways [11, 12]. The gene discussed is VEGFA; the disease is Hypertension.